ETON
Eton Pharmaceuticals Inc
59.50$
+7.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +110.7% | -39.7% | +54.2% | +4.4% | -8.9% | +26.8% | +139.8% | +21.0% | |
| – | +106.9% | -45.4% | +64.6% | -4.4% | -15.3% | +34.2% | +52.8% | +47.7% | |
| – | +103.2% | -54.9% | +76.5% | -32.4% | +13.2% | +31.2% | -30.2% | +73.7% | |
| – | +103.2% | -54.9% | +76.5% | -32.4% | +13.2% | +31.2% | -30.2% | +73.7% | |
| – | – | – | -89.9% | +11,297.9% | -66.1% | +84.2% | +57.2% | +119.3% | |
| – | – | – | +226.8% | -55.7% | +1.3% | +63.6% | +1,572.0% | +1.2% | |
| – | +549.6% | +65.2% | -21.5% | -78.2% | -67.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | -20.7% | +529.7% | +31.3% | -0.3% | +636.0% | -11.5% | |
| – | +54.2% | +222.2% | +63.4% | -7.7% | +21.5% | +36.1% | +217.9% | +27.6% | |
| – | +155.2% | -3.0% | +93.3% | +20.1% | +41.8% | +151.4% | +22.8% | +93.0% | |
| – | – | – | +110.5% | +406.4% | -27.2% | +420.8% | -98.6% | +11,464.5% | |
| – | +163.6% | -59.5% | +307.7% | -24.3% | -0.5% | +4.6% | +125.5% | +163.4% | |
| – | – | – | +49.0% | -22.2% | +2.3% | – | – | -27.0% | |
| – | +116.8% | -59.9% | +48.5% | +12.6% | -25.8% | +18.3% | +57.8% | +7.1% | |
| – | – | – | – | – | – | – | – | – | |
| – | -63.2% | +176.7% | +18.3% | +20.0% | -0.2% | +2.0% | +1.0% | +3.9% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.